Mutations in the proximal binding site and F-loop of AdeJ confer resistance to efflux pump inhibitors

  • Aysegul Saral Sariyer
  • , Inga V. Leus
  • , Rushikesh Tambat
  • , Mithila Farjana
  • , Marcela Olvera
  • , Shalini J. Rukmani
  • , Emrah Sariyer
  • , Jeremy C. Smith
  • , Jerry M. Parks
  • , John K. Walker
  • , Helen I. Zgurskaya

Research output: Contribution to journalArticlepeer-review

Abstract

Multidrug efflux is one of the major mechanisms of antibiotic resistance in gram-negative bacteria. Inhibitors of efflux pumps potentiate the activities of antibiotics, and their discovery could lead to new therapeutic options. The AdeIJK pump in Acinetobacter baumannii is a promising target for efflux pump inhibitors (EPIs) due to its high clinical importance and conservation, and several classes of EPIs targeting this and other A. baumannii efflux transporters have been recently reported. However, the mechanisms of action of these EPIs and their resistance liability remain underexplored. Here, we analyzed the impact of site-specific substitutions in the substrate/EPI translocation path of the inner membrane transporter AdeJ on efflux of substrate antibiotics and fluorescent probes and activities of substituted 4,6-diaminoquinoline EPIs. We found that substitutions in amino acid residues located in the entrance cleft (R701) and the flexible loop (E675) of AdeJ lead to resistance specifically against biphenyl-substituted EPIs, whereas the substitution of F178 in the distal binding pocket increased AdeJ sensitivity to certain naphthyl- and biphenyl-substituted EPIs. No major differences in docking scores and poses of substrates and EPIs were observed between the wild type and corresponding AdeJ variants for any of the mutations considered. This study concludes that substrates and EPIs bound along the translocation path of AdeJ participate in its conformational transitions and can either increase or decrease the rate of transport and therefore the efficiency of EPIs.

Original languageEnglish
JournalAntimicrobial Agents and Chemotherapy
Volume69
Issue number8
DOIs
StatePublished - Aug 2025

Funding

This study was supported by the National Institutes of Health grant AI052293 to H.I.Z., J.K.W., J.C.S., and J.M.P. and a scholarship from the and Technological Research Council of Turkey (TUBİTAK 2219) to A.S.S. and E.S.

Keywords

  • Acinetobacter
  • antibiotic resistance
  • efflux pump inhibitors
  • multidrug efflux

Fingerprint

Dive into the research topics of 'Mutations in the proximal binding site and F-loop of AdeJ confer resistance to efflux pump inhibitors'. Together they form a unique fingerprint.

Cite this